Elucid
Clinically validated medical-imaging software that analyzes CT angiography to characterize arterial plaque and help clinicians assess cardiovascular risk.
$55MSeries D
ParticipantIC
IAG Capital Partners
Activity from announced rounds
Activity in this selectionSeries C+
IAG Capital Partners is the Charleston investment firm identified in its own Xscape portfolio and investment announcement.
Recorded funding activity
The recorded activity includes Arcee’s open-weight models, ReEmerge’s therapy for chronic cognitive impairment and Cornelis’ high-speed computing-network fabrics. The full firm identity distinguishes it from unrelated angel and airline organizations using IAG.
- Rounds participated in
- 1
- Confirmed lead rounds
- 0 All roles disclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $55M 1 disclosed · full round size, not this investor’s share